ECCO2R - Mechanical Power Study

Status Recruiting

Clinical Trial Summary

Although mechanical ventilation remains the cornerstone of ARDS treatment, several experimental and clinical studies have undoubtedly demonstrated that it can contribute to high mortality through the developing of ventilator induced lung injury even in patients with plateau pressure <30 cmH2O. Since now there are no studies exploring the application of low flow extracorporeal CO2 removal and ultraprotective ventilation to reduce mechanical power, a composite index of VILI, independently from the value of plateau pressure or the severity of hypercapnia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

ARDS, Human
Extracorporeal CO2 Removal
Mechanical Power
Respiratory Distress Syndrome, Adult

Clinical Trial Details

NCT number	NCT03939260
Study type	Observational
Source	University of Milan
Contact	Davide Chiumello, Professor
Phone	+390281844020
Email	chiumello@libero.it
Status	Recruiting
Phase
Start date	March 20, 2019
Completion date	March 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06444750` - Comparison of the Proteome in ICU Patients in Search for TRALI Biomarkers
Not yet recruiting	`NCT05306392` - Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation	N/A
Completed	`NCT04719182` - Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Terminated	`NCT04954014` - Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients	Phase 2
Completed	`NCT04274296` - Advisory Lead ARDS Respirator Management
Recruiting	`NCT03215316` - Screening Expiratory Flow Limitation by Flow-time Curve	N/A
Recruiting	`NCT04115514` - Treatment of ARDS With Instilled T3	Phase 2
Not yet recruiting	`NCT05061212` - The Mechanism of Extracellular Vesicles Containing Mitochondrial DNA in ARDS Lung Injury Caused by Extrapulmonary Sepsis
Not yet recruiting	`NCT04556864` - Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19
Completed	`NCT05693051` - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Recruiting	`NCT04174014` - Optimal PEEP Titration Combining Transpulmonary Pressure Measurement and Electric Impedance Tomography	N/A
Enrolling by invitation	`NCT06164639` - Potential Biomarkers for Reflux Aspiration-induced Lung Injury.
Terminated	`NCT05384379` - Efficacy and Safety Evaluation of BZ371B in ARDS Patients	Early Phase 1
Completed	`NCT04375735` - London's Exogenous Surfactant Study for COVID19	Phase 1/Phase 2
Completed	`NCT06224010` - Respiratory Drive and Inspiratory Effort in COVID-19 Associated ARDS
Not yet recruiting	`NCT04530188` - Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS	Phase 3
Completed	`NCT03405038` - Prone Position Impact in ARDS Patients on the Incidence of Central Venous Catheter Colonization
Recruiting	`NCT05148026` - Regional Citrate Anticoagulation for RRT During V-V ECMO	N/A
Recruiting	`NCT04390360` - Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction	N/A
Completed	`NCT06197256` - Cardiac Dysfunction in Critically Ill Covid-19 Patients